Renalytix Plc (AIM:RENX)
London · Delayed Price · Currency is GBP · Price in GBX 4.150
0.00 (0.00%)
Aug 28, 2026, 5:15 PM GMT
Renalytix Market Cap
Renalytix has a market cap or net worth of 18.14 million as of September 4, 2026. Its market cap has decreased by -6.40% in one year.
Market Cap
18.14M
Enterprise Value
17.84M
Revenue
2.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.15
ChartMarket Cap Chart
Since November 6, 2018, Renalytix's market cap has decreased from 64.58M to 18.14M, a decrease of -71.92%. That is a compound annual growth rate of -15.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 18.14M | -29.66% |
| Dec 31, 2025 | 25.78M | -27.58% |
| Dec 31, 2024 | 35.60M | 129.87% |
| Dec 29, 2023 | 15.49M | -71.47% |
| Dec 30, 2022 | 54.30M | -87.89% |
| Dec 31, 2021 | 448.32M | 27.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Craneware | 470.21M |
| Optima Health | 265.41M |
| Diaceutics | 124.35M |
| MedPal AI | 40.41M |
| Cambridge Cognition Holdings | 14.43M |
| Feedback | 3.00M |
| Imaging Biometrics | 1.97M |
| Trellus Health | 172.05K |